CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
Honor Your StaffCelebrate Lab Week, and honor yourself and your colleagues as a vital part of the la...
As a reminder, CTS will be exhibiting this weekend at the AABB Annual Meeting in San Antonio, T...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...